Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial

Authors

Sebastian Häckl
Armin Koch
Bernhard M. W. Schmidt (ORCID: https://orcid.org/0000-0002-7351-565X)
Julian Glandorf (ORCID: https://orcid.org/0000-0003-1927-9876)
Vera Christine Wulfmeyer
Jessica Kaufeld (ORCID: https://orcid.org/0000-0001-7718-3464)
Stefanie D. Krämer (ORCID: https://orcid.org/0000-0002-0426-4340)
Roland Schmitt (ORCID: https://orcid.org/0000-0003-4415-8355)
Kai Martin Schmidt-Ott (ORCID: https://orcid.org/0000-0002-7700-7142)
Elisabeth Bahlmann-Kroll
Dagmar Hartung

Institutions

Medizinische Hochschule Hannover (DE)
University Hospital Schleswig-Holstein (DE)
University of Lübeck (DE)

Publication Details

Journal: BMJ Open
Published: 2024-12-01
DOI: https://doi.org/10.1136/bmjopen-2024-088317
Citations: 9
Primary Topic: Genetic and Kidney Cyst Diseases
Type: article
Field-Weighted Citation Impact: 4.95

Funders

Boehringer Ingelheim
Bundesinstitut für Arzneimittel und Medizinprodukte
Medizinischen Hochschule Hannover

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial

Sebastian Häckl, Armin Koch, Bernhard M. W. Schmidt, Julian Glandorf et al.

Dec 1, 2024

9 citations

BMJ Open

Genetic and Kidney Cyst Diseases

4.95

article

Empagliflozin in patients with autosomal dominant polycystic kidney disease (EMPA-PKD): study protocol for a randomised controlled trial

Sebastian Häckl, Armin Koch, Bernhard M. W. Schmidt, Julian Glandorf, Vera Christine Wulfmeyer, Jessica Kaufeld, Stefanie D. Krämer, Roland Schmitt, Kai Martin Schmidt-Ott, Elisabeth Bahlmann-Kroll, Dagmar Hartung

December 1, 2024article en

9 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 14(12)

Medizinische Hochschule Hannover (DE), University Hospital Schleswig-Holstein (DE), University of Lübeck (DE)

Boehringer Ingelheim, Bundesinstitut für Arzneimittel und Medizinprodukte, Medizinischen Hochschule Hannover

Good health and well-being

Openalex Percentile: Top 4%

Genetic and Kidney Cyst Diseases

4.95

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.